NYU Langone Division of Gastroenterology & GI Surgery 2015 Year in Review
Transformative, Multidisciplinary, Pioneering: Our 2015 Year in Review highlights our advances in care for patients with complex GI conditions.Download PDF
Inside This Issue
In 2015, we worked collaboratively to help forge a better future with more effective options in the screening, prevention, diagnosis, and treatment of esophageal, gastric, hepatic, pancreatic, intestinal, and colorectal diseases. Over the last year, we deepened our focus into the human microbiome and its role in numerous disease states—including obesity, inflammatory bowel disease, colorectal cancer, and pancreatic cancer—to reveal mechanisms and markers that can be targeted for intervention.
To advance treatment outcomes for pancreatic disease, we led the exploration of two new innovative technologies: irreversible electroporation (IRE) and needle-based confocal laser endomicroscopy (nCLE). We also received a new T32 research training grant from the National Institutes of Health that will be used to help support physician-scientists interested in GI cancer.
In 2016, we will continue to build upon our tradition of excellence in education by releasing our Gastroenterology Fellowship Program Director’s Toolkit, which will be made available nationwide in collaboration with the American College of Gastroenterology.
Highlights of our annual report include:
- Human Microbiome and Cancer Risk
- Pancreatic Disease: Innovative Technologies
- Colon Cancer: Tackling Colon Cancer
- Inflammatory Bowel Disease: Transforming the Lives of Patients
- Obesity: Validating Outcomes of Bariatric Surgery and Embracing New Techniques
- Education: A National Leader in Medical Education